- Home
- VRAR vs DXR Comparison
VRAR vs DXR Comparison
Compare VRAR & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAR
- DXR
- Stock Information
- Founded
- VRAR 2016
- DXR 1970
- Country
- VRAR United States
- DXR United States
- Employees
- VRAR N/A
- DXR N/A
- Industry
- VRAR Retail: Computer Software & Peripheral Equipment
- DXR Medical/Dental Instruments
- Sector
- VRAR Technology
- DXR Health Care
- Exchange
- VRAR Nasdaq
- DXR Nasdaq
- Market Cap
- VRAR 42.4M
- DXR 37.6M
- IPO Year
- VRAR 2021
- DXR N/A
- Fundamental
- Price
- VRAR $1.95
- DXR $8.50
- Analyst Decision
- VRAR Strong Buy
- DXR Strong Buy
- Analyst Count
- VRAR 1
- DXR 1
- Target Price
- VRAR $4.67
- DXR $24.75
- AVG Volume (30 Days)
- VRAR 5.7M
- DXR 6.8K
- Earning Date
- VRAR 02-12-2025
- DXR 01-01-0001
- Dividend Yield
- VRAR N/A
- DXR N/A
- EPS Growth
- VRAR N/A
- DXR N/A
- EPS
- VRAR N/A
- DXR 0.35
- Revenue
- VRAR $8,137,688.00
- DXR $154,205.00
- Revenue This Year
- VRAR $39.02
- DXR N/A
- Revenue Next Year
- VRAR N/A
- DXR N/A
- P/E Ratio
- VRAR N/A
- DXR $24.39
- Revenue Growth
- VRAR N/A
- DXR N/A
- 52 Week Low
- VRAR $0.50
- DXR $7.19
- 52 Week High
- VRAR $7.00
- DXR $10.02
- Technical
- Relative Strength Index (RSI)
- VRAR 46.96
- DXR 54.80
- Support Level
- VRAR $1.86
- DXR $8.01
- Resistance Level
- VRAR $2.17
- DXR $8.51
- Average True Range (ATR)
- VRAR 0.38
- DXR 0.31
- MACD
- VRAR -0.16
- DXR 0.10
- Stochastic Oscillator
- VRAR 14.41
- DXR 99.07
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.